La Bonte, Laura R <br/><br/>
Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion.  [electronic resource] 

 -  American journal of physiology. Heart and circulatory physiology  Mar 2008 
 - H1282-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0363-6135 
<br/><br/><label>Standard No.: </label>10.1152/ajpheart.00843.2007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzamidines<br/>Blood Cell Count<br/>Blood Glucose--metabolism<br/>Blood Pressure--physiology<br/>CD11b Antigen--biosynthesis<br/>Cell Adhesion Molecules--biosynthesis<br/>Cell Death--physiology<br/>Complement Activation--drug effects<br/>Complement C3--metabolism<br/>Complement Inactivating Agents--therapeutic use<br/>Complement System Proteins--metabolism<br/>Diabetes Mellitus, Type 2--genetics<br/>Diabetic Angiopathies--pathology<br/>Flow Cytometry<br/>Guanidines--pharmacology<br/>Heart Rate--physiology<br/>Intercellular Adhesion Molecule-1--biosynthesis<br/>Male<br/>Myocardial Infarction--pathology<br/>Myocardial Reperfusion Injury--pathology<br/>Neutrophils--metabolism<br/>Rats<br/>Rats, Zucker